Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 8, 2013
Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA databaseS Rusconi, P Vitiello, F Adorni, et al.Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parametersB Capiluppi, D Ciuffreda, G P Quinzan, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 17, 2012
Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagusD F Boerwinkel, M Di Pietro, X Liu, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 22, 2012
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patientsF Saladini, G Meini, C Bianco, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 15, 2009
Insulin resistance is a risk factor for high blood pressure regardless of body size and fat distribution in obese childrenC Maffeis, C Banzato, P Brambilla, et al.Molecular Biology of the Cell|December 22, 2006
BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organellesSubba Rao Gangi Setty, Danièle Tenza, Steven T Truschel, et al.Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|December 14, 2016
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapiesM Ruggieri, A D Praticò, A Serra, et al.Nature Communications|March 18, 2022
Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activityA C Katz-Summercorn, S Jammula, A Frangou, et al.Gut|December 26, 2014
Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registryR J Haidry, M A Butt, J M Dunn, et al.Pageof 12